NAD(P)H: Quinone oxidoreductase 1 is induced by progesterone in cardiomyocytes

Cardiovascular Toxicology

Volumn 12, Issue 2, 2012, Pages 108-114

  Morrissy, Stephen ^a,b   Strom, Joshua ^a   Purdom Dickinson, Sally ^a   Chen, Qin M ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Antioxidant; Apoptosis; Cardiac protection; Steroids

Indexed keywords

BETA NAPHTHOFLAVONE; CASPASE 3; DICOUMAROL; PROGESTERONE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE) 1; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE; GENE FUNCTION; GENE INDUCTION; HEART MUSCLE CELL; HEART PROTECTION; NONHUMAN; NOQ1 GENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; ANIMALS, NEWBORN; CELLS, CULTURED; CYTOPROTECTION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INDUCTION; MYOCYTES, CARDIAC; NAD(P)H DEHYDROGENASE (QUINONE); PROGESTERONE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84864665695     PISSN: 15307905     EISSN: 15590259     Source Type: Journal    
DOI: 10.1007/s12012-011-9144-9     Document Type: Article

References (47)

1. Keizer, H. G., Pinedo, H. M., Schuurhuis, G. J., & Joenje, H. (1990). Doxorubicin (adriamycin): A critical review of free radical-dependent mechanisms of cytotoxicity. Pharmacology and Therapeutics, 47, 219-231.
2. Singal, P. K., & Iliskovic, N. (1998). Doxorubicin-induced car-diomyopathy. New England Journal of Medicine, 339, 900-905.
3. Singal, P. K., Li, T., Kumar, D., Danelisen, I., & Iliskovic, N. (2000). Adriamycin-induced heart failure: Mechanism and modulation. Molecular and Cellular Biochemistry, 207, 77-86.
4. Lefrak, E. A., Pitha, J., Rosenheim, S., & Gottlieb, J. A. (1973). A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer, 32, 302-314.
5. Bristow, M. R., Thompson, P. D., Martin, R. P., Mason, J. W., Billingham, M. E., & Harrison, D. C. (1978). Early anthracycline cardiotoxicity. American Journal of Medicine, 65, 823-832.
6. Unverferth, B. J., Magorien, R. D., Balcerzak, S. P., Leier, C. V., & Unverferth, D. V. (1983). Early changes in human myocardial nuclei after doxorubicin. Cancer, 52, 215-221.
7. Chen, Q. M., Alexander, D., Sun, H., Xie, L., Lin, Y., Terrand, J., et al. (2005). Corticosteroids inhibit cell death induced by doxorubicin in cardiomyocytes: Induction of antiapoptosis, anti-oxidant, and detoxification genes. Molecular Pharmacology, 67, 1861-1873.
8. Morrissy, S., Xu, B., Aguilar, D., Zhang, J., & Chen, Q. M. (2010). Inhibition of apoptosis by progesterone in cardiomyo-cytes. Aging Cell, 9, 799-809.
9. Kang, Y. J., Chen, Y., Yu, A., Voss-McCowan, M., & Epstein, P. N. (1997). Overexpression of metallothionein in the heart of transgenic mice suppresses doxorubicin cardiotoxicity. Journal of Clinical Investigation, 100, 1501-1506.
10. Kang, Y. J., Chen, Y., & Epstein, P. N. (1996). Suppression of doxorubicin cardiotoxicity by overexpression of catalase in the heart of transgenic mice. Journal of Biological Chemistry, 271, 12610-12616.
11. Davies, K. J., & Doroshow, J. H. (1986). Redox cycling of anthracyclines by cardiac mitochondria. I. Anthracycline radical formation by NADH dehydrogenase. Journal of Biological Chemistry, 261, 3060-3067.
12. Doroshow, J. H., & Davies, K. J. (1986). Redox cycling of anthracyclines by cardiac mitochondria. II. Formation of superoxide anion, hydrogen peroxide, and hydroxyl radical. Journal of Biological Chemistry, 261, 3068-3074.
13. Demirbag, R., Yilmaz, R., & Erel, O. (2005). The association of total antioxidant capacity with sex hormones. Scandinavian Cardiovascular Journal, 39, 172-176.
14. Bednarek-Tupikowska, G., Tupikowski, K., Bidzinska, B., Bohdanowicz-Pawlak, A., Antonowicz-Juchniewicz, J., Kosowska, B., etal. (2004). Serum lipid peroxides and total antioxidant status in postmenopausal women on hormone replacement therapy. Gynecological Endocrinology, 19, 57-63.
15. Goldstein, J., Sites, C. K., & Toth, M. J. (2004). Progesterone stimulates cardiac muscle protein synthesis via receptor-dependent pathway. Fertility and Sterility, 82, 430-436.
16. Lind, C., Hochstein, P., & Ernster, L. (1982). DT-diaphorase as a quinone reductase: A cellular control device against semiquinone and superoxide radical formation. Archives of Biochemistry and Biophysics, 216, 178-185.
17. Kensler, T. W., Wakabayashi, N., & Biswal, S. (2007). Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annual Review of Pharmacology and Toxicology, 47, 89-116.
18. Nguyen, T., Nioi, P., & Pickett, C. B. (2009). The Nrf2-antiox-idant response element signaling pathway and its activation by oxidative stress. Journal of Biological Chemistry, 284, 13291-13295.
19. Dinkova-Kostova, A. T., & Talalay, P. (2000). Persuasive evidence that quinone reductase type 1 (DT diaphorase) protects cells against the toxicity of electrophiles and reactive forms of oxygen. Free Radical Biology and Medicine, 29, 231-240.
20. Benson, A. M., Hunkeler, M. J., & Talalay, P. (1980). Increase of NAD(P)H: Quinone reductase by dietary antioxidants: Possible role in protection against carcinogenesis and toxicity. Proceedings of the National Academy of Sciences of the United States of America, 77, 5216-5220.
21. Gutierrez, P. L. (2000). The role of NAD(P)H oxidoreductase (DT-Diaphorase) in the bioactivation of quinone-containing antitumor agents: A review. Free Radical Biology and Medicine, 29, 263-275.
22. Floreani, M., Napoli, E., Quintieri, L., & Palatini, P. (2003). Oral administration of trans-resveratrol to guinea pigs increases cardiac DT-diaphorase and catalase activities, and protects isolated atria from menadione toxicity. Life Sciences, 72, 2741-2750.
23. Asher, G., Lotem, J., Kama, R., Sachs, L., & Shaul, Y. (2002). NQO1 stabilizes p53 through a distinct pathway. Proceedings of the National Academy of Sciences of the United States of America, 99, 3099-3104.
24. Anwar, A., Dehn, D., Siegel, D., Kepa, J. K., Tang, L. J., Pietenpol, J. A., et al. (2003). Interaction of human NAD(P)H: Quinone oxidoreductase 1 (NQO1) with the tumor suppressor protein p53 in cells and cell-free systems. Journal of Biological Chemistry, 278, 10368-10373.
25. Iskander, K., Gaikwad, A., Paquet, M., Long, D. J., II, Brayton, C., Barrios, R., et al. (2005). Lower induction of p53 and decreased apoptosis in NQO1-null mice lead to increased sensitivity to chemical-induced skin carcinogenesis. Cancer Research, 65, 2054-2058.
26. Jain, S. K., Rogier, K., & Prouty, L. (2004). Protective effects of 17beta-estradiol and trivalent chromium on interleukin-6 secretion, oxidative stress, and adhesion of monocytes: Relevance to heart disease in postmenopausal women. Free Radical Biology and Medicine, 37, 1730-1735.
27. Moorthy, K., Sharma, D., Basir, S. F., & Baquer, N. Z. (2005). Administration of estradiol and progesterone modulate the activities of antioxidant enzyme and aminotransferases in naturally menopausal rats. Experimental Gerontology, 40, 295-302.
28. Capel, I. D., Jenner, M., Williams, D. C., Donaldson, D., & Nath, A. (1981). The effect of prolonged oral contraceptive steroid use on erythrocyte glutathione peroxidase activity. Journal of Steroid Biochemistry, 14, 729-732.
29. Sugioka, K., Shimosegawa, Y., & Nakano, M. (1987). Estrogens as natural antioxidants of membrane phospholipid peroxidation. Federation of European Biochemical Societies Letters, 210, 37-39.
30. Bednarek-Tupikowska, G., Bohdanowicz-Pawlak, A., Bidzinska, B., Milewicz, A., Antonowicz-Juchniewicz, J., & Andrzejak, R. (2001). Serum lipid peroxide levels and erythrocyte glutathione peroxidase and superoxide dismutase activity in premenopausal and postmenopausal women. Gynecological Endocrinology, 15, 298-303.
31. Massafra, C., Buonocore, G., Gioia, D., Sargentini, I., & Farina, G. (1997). Effects of estradiol and medroxyprogesterone-acetate treatment on erythrocyte antioxidant enzyme activities and mal-ondialdehyde plasma levels in amenorrheic women. Journal of Clinical Endocrinology and Metabolism, 82, 173-175.
32. Ozden, S., Dildar, K., Kadir, Y. H., & Gulizar, K. (2001). The effects of hormone replacement therapy on lipid peroxidation and antioxidant status. Maturitas, 38, 165-170.
33. Tranquilli, A. L., Mazzanti, L., Cugini, A. M., Cester, N., Garzetti, G. G., & Romanini, C. (1995). Transdermal estradiol and medroxyprogesterone acetate in hormone replacement therapy are both antioxidants. Gynecological Endocrinology, 9, 137-141.
34. Kurita, T., Wang, Y. Z., Donjacour, A. A., Zhao, C., Lydon, J. P., O'Malley, B. W., et al. (2001). Paracrine regulation of apoptosis by steroid hormones in the male and female reproductive system. Cell Death and Differentiation, 8, 192-200.
35. Liszewska, E., Rekawiecki, R., & Kotwica, J. (2005). Effect of progesterone on the expression of bax and bcl-2 and on caspase activity in bovine luteal cells. Prostaglandins & Other Lipid Mediators, 78, 67-81.
36. Okuda, K., Korzekwa, A., Shibaya, M., Murakami, S., Nishim-ura, R., Tsubouchi, M., et al. (2004). Progesterone is a suppressor of apoptosis in bovine luteal cells. Biology of Reproduction, 71, 2065-2071.
37. Peluso, J. J. (2006). Multiplicity of progesterone's actions and receptors in the mammalian ovary. Biology of Reproduction, 75, 2-8.
38. Kuebler, J. F., Jarrar, D., Bland, K. I., Rue, L., III, Wang, P., & Chaudry, I. H. (2003). Progesterone administration after trauma and hemorrhagic shock improves cardiovascular responses. Critical Care Medicine, 31, 1786-1793.
39. Knowlton, A. A., & Sun, L. (2001). Heat-shock factor-1, steroid hormones, and regulation of heat-shock protein expression in the heart. American Journal of Physiology. Heart and Circulatory Physiology, 280, H455-H464.
40. Lin, A. L., McGill, H. C., Jr., & Shain, S. A. (1982). Hormone receptors of the baboon cardiovascular system. Biochemical characterization of aortic and myocardial cytoplasmic progesterone receptors. Circulation Research, 50, 610-616.
41. Horowitz, K. B., & Horwitz, L. D. (1982). Canine vascular tissues are targets for androgens, estrogens, progestins and gluco-corticoids. Journal of Clinical Investigation, 69, 750-758.
42. Rylance, P. B., Brincat, M., Lafferty, K., De Trafford, J. C., Brincat, S., Parsons, V., et al. (1985). Natural progesterone and antihypertensive action. British Medical Journal (Clinical Research ed.), 290, 13-14.
43. Regensteiner, J. G., Hiatt, W. R., Byyny, R. L., Pickett, C. K., Woodard, W. D., & Moore, L. G. (1991). Short-term effects of estrogen and progestin on blood pressure of normotensive post-menopausal women. Journal of Clinical Pharmacology, 31, 543-548.
44. Gibson, C. L., Coomber, B., & Rathbone, J. (2009). Is progesterone a candidate neuroprotective factor for treatment following ischemic stroke? Neuroscientist, 15, 324-332.
45. Gonzalez Deniselle, M. C., Lopez Costa, J. J., Gonzalez, S. L., Labombarda, F., Garay, L., Guennoun, R., et al. (2002). Basis of progesterone protection in spinal cord neurodegeneration. Journal of Steroid Biochemistry and Molecular Biology, 83, 199-209.
46. Jiang, N., Chopp, M., Stein, D., & Feit, H. (1996). Progesterone is neuroprotective after transient middle cerebral artery occlusion in male rats. Brain Research, 735, 101-107.
47. Roof, R. L., & Hall, E. D. (2000). Gender differences in acute CNS trauma and stroke: Neuroprotective effects of estrogen and progesterone. Journal of Neurotrauma, 17, 367-388.